Comparison of Once Daily Fluticasone Furoate/Vilanterol With Twice Daily Fluticasone Propionate/Salmeterol in Patients With Controlled Asthma

被引：2
|
作者：
Bernstein, David
Forth, Richard
Yates, Louisa
Andersen, Leslie
Jacques, Loretta
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[2] Bernstein Clin Res Ctr, Cincinnati, OH USA
来源：
CHEST | 2017年 / 152卷 / 04期
关键词：
D O I：
10.1016/j.chest.2017.08.217
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：186A / 186A
页数：1
相关论文
共 50 条
  • [21] Once daily cicelsonide is as effective as twice daily fluticasone propionate in improving lung function in patients with asthma
    Buhl, R
    Wolf, S
    Tiesler, C
    Escher, A
    Engelstätter, R
    THORAX, 2004, 59 (01) : 71 - 72
  • [22] Once-Daily (od) Fluticasone Furoate/vilanterol (ff/vi: 100/25mcg) Compared With Twice-Daily (bd) Fluticasone Propionate/salmeterol (fsc: 250/50mcg) In Patients With COPD
    Dransfield, M. T.
    Crim, C. C.
    Feldman, G.
    Korenblat, P. E.
    Laforce, C.
    Locantore, N.
    Pistolesi, M.
    Watkins, M.
    Martinez, F. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [23] Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy
    Henrik Svedsater
    Gillian Stynes
    Jaro Wex
    Lucy Frith
    David Leather
    Emanuela Castelnuovo
    Michelle Detry
    Scott Berry
    Asthma Research and Practice, 2 (1)
  • [24] Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study
    Nakamura, Yoichi
    Hozawa, Soichiro
    Sagara, Hironori
    Ohbayashi, Hiroyuki
    Lee, Laurie A.
    Crawford, Jodie
    Tamaoki, Jun
    Nishi, Takanobu
    Fowler, Andrew
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1657 - 1665
  • [25] The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma
    Malone, R
    LaForce, C
    Nimmagadda, S
    Schoaf, L
    House, K
    Ellsworth, A
    Dorinsky, P
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 95 (01) : 66 - 71
  • [26] The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing
    Kempsford, Rodger D.
    Oliver, Amanda
    Bal, Joanne
    Tombs, Lee
    Quinn, Dean
    RESPIRATORY MEDICINE, 2013, 107 (12) : 1873 - 1880
  • [27] Once daily inhaled fluticasone propionate is as effective as twice daily in children with stable mild to moderate asthma
    Hodges, I
    Netherway, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A139 - A139
  • [28] Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Hashimoto, Dai
    Kamiya, Yousuke
    Yasui, Hideki
    Karayama, Masato
    Suzuki, Yuzo
    Hozumi, Hironao
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inui, Naoki
    Suda, Takafumi
    JOURNAL OF ASTHMA AND ALLERGY, 2019, 12 : 253 - 261
  • [29] Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction
    Martin, Neil
    Weiler, John M.
    Pearlman, David
    Jacques, Loretta
    Nunn, Carol
    Forth, Richard
    West, Sarah
    Dunn, Karen
    O'Byrne, Paul M.
    JOURNAL OF ASTHMA, 2020, 57 (04) : 431 - 440
  • [30] Efficacy and safety of mometasone furoate 0.1% once daily versus fluticasone propionate 0.005% twice daily in the management of psoriasis
    De Villez, RL
    Sher, AM
    Breneman, DL
    Espy, PD
    Garcia, CJ
    Monroe, EW
    Tanner, DJ
    Cuffie, CA
    ADVANCES IN THERAPY, 1998, 15 (02) : 92 - 97
12345